Sartorius Stedim Biotech (XPAR:DIM) Other Net Income (Loss) : €-0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Sartorius Stedim Biotech Other Net Income (Loss)?

Sartorius Stedim Biotech's Other Net Income (Loss) for the three months ended in Dec. 2023 was €-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0 Mil.

Sartorius Stedim Biotech's quarterly Other Net Income (Loss) stayed the same from Jun. 2023 (€0 Mil) to Sep. 2023 (€0 Mil) but then declined from Sep. 2023 (€0 Mil) to Dec. 2023 (€-0 Mil).

Sartorius Stedim Biotech's annual Other Net Income (Loss) stayed the same from Dec. 2021 (€-0 Mil) to Dec. 2022 (€-0 Mil) but then increased from Dec. 2022 (€-0 Mil) to Dec. 2023 (€-0 Mil).

Sartorius Stedim Biotech Other Net Income (Loss) Historical Data

The historical data trend for Sartorius Stedim Biotech's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Other Net Income (Loss) Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-0.10

Sartorius Stedim Biotech Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0 Mil.

Sartorius Stedim Biotech Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech (XPAR:DIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (XPAR:DIM) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

SRTOY:USA SDMHF:USA DIM:Mexico DIMp:UK 0RG8:UK 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.